April 8, 2014
LEXINGTON, Mass. – N-of-One, Inc., the leading provider of clinical interpretation for precision medicine in oncology, today announced an agreement with Dartmouth-Hitchcock Medical Center in Lebanon, NH to provide clinical interpretation for Dartmouth-Hitchcock’s Next-Generation Sequencing tests as part of Norris Cotton Cancer Center’s comprehensive molecular diagnostics and treatment program. Financial terms of the agreement are [...]
April 8, 2014
INDIANAPOLIS, IND. AND BREA, CALIF. -- hc1.com®, the Healthcare Relationship Cloud™ company, and Beckman Coulter Diagnostics, a global leader in developing clinical diagnostic products that help advance and optimize the laboratory, announced a strategic partnership to deliver innovative technology to laboratories that turn large amounts of clinical data into actionable insights that transform how labs [...]
PROTEA ANNOUNCES EXPANSION OF TEAM AND TECHNOLOGY
April 8, 2014
MORGANTOWN, W.V. -- Protea Biosciences Group, Inc. (OTCBB:PRGB) ("Protea"), announced today that Greg Kilby, Ph.D. has joined the Company as its Chief Bioanalytics Officer (CBO) and Director of Biomolecular Information Services. Prior to joining Protea Dr. Kilby held the position of Director, North America Life Sciences Mass Spectrometry Application and Demonstration Laboratories for Thermo Fisher [...]
Boost throughput and walkaway times with Tecan’s new Nested LiHa Disposable Tips
April 8, 2014
Männedorf, Switzerland – The demand for ever-increasing throughput means that many laboratories are looking for solutions to increase the capacity of their automated systems. Tecan has created Nested LiHa Disposable Tips specifically to meet this need, allowing up to five racks of the new 350 ?l tips to be stacked on a single SLAS-format carrier. [...]
GE Introduces New Sievers* M9 Total Organic Carbon Analyzer for Ultrapure and Process Waters
April 8, 2014
SAN ANTONIO — GE (NYSE: GE) today announced the release of its new Sievers* M9 Total Organic Carbon (TOC) Analyzer, which has been designed to measure TOC in a broad range of samples from ultrapure water to process waters. The new M9 Analyzer enhances productivity by producing TOC results in two minutes, twice as fast [...]
Emerson awarded $15 million contract to modernize controls at Colorado’s second-largest power plant
April 7, 2014
PITTSBURGH — Emerson Process Management has been awarded a $15 million contract to engineer and install its Ovation™ control system at Craig Station, the second-largest power generating facility in Colorado. The three-unit, 1,311-MW plant is an important regional baseload resource that is operated by Tri-State Generation and Transmission Association, a wholesale electric power supplier serving [...]
April 7, 2014
BILLERICA, Mass and SAN DIEGO —— RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetics, today announced the availability of its ThunderBolts™ Cancer Panel, a comprehensive next-generation DNA sequencing (NGS)solution that enables researchers to profile a wide range of tumor samples in fewer than two days for as low as $100 [...]
Ex-Vivo Device for Removal of Dying and Dead Cells
April 7, 2014
AMSBIO announces ClioCell™ - an ex-vivo device for removal of dying and dead cells, improving viability and quality of cell populations and their subsequent productivity. The system comprises super-paramagnetic nanoparticles which have been coupled with proprietary elements that bind to dead and dying cells and cell debris. The resultant product selectively initiates dead-cell removal, emulating [...]
Roche acquires IQuum to strengthen offerings in molecular diagnostics
April 7, 2014
IQuum’s unique products will allow Roche to quickly enter the point of care segment of molecular diagnostics Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of IQuum, Inc. (IQuum) based in Marlborough, Massachusetts, USA. IQuum is a privately held company focused on developing point of care offerings for the molecular diagnostics market. Under [...]
HTG Molecular Diagnostics and OvaGene Oncology Partner on Gynecologic Cancer Tests
April 7, 2014
TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc., (HTG) and OvaGene Oncology have entered a manufacturing supply agreement where OvaGene will design and develop their proprietary gene expression assays on HTG’s fully automated, extraction-free Edge Platform. The HTG Edge System is the only extraction-free, automated gene expression platform that delivers affordable, multiplexed results on lysed samples [...]

